Corporate
TG Therapeutics Eyes $900M Revenue as BRIUMVI Takes Market Share from Roche, Novartis
Jan 14
You're signed outSign in or to get full access.
TG THERAPEUTICS (TGTX) Earnings Call Transcripts
Browse quarterly earnings call transcripts for TG THERAPEUTICS.
Q4 2025
Feb 26, 2026
Q3 2025
Nov 3, 2025
Q2 2025
Aug 4, 2025
Q1 2025
May 5, 2025
Q4 2024
Mar 3, 2025
Q3 2024
Nov 4, 2024
Q2 2024
Aug 6, 2024
Q1 2024
May 1, 2024
Q4 2023
Feb 28, 2024
Q3 2023
Nov 1, 2023
Q2 2023
Aug 1, 2023